Infinity Pharmaceuticals Inc. INFI

NAS: INFI | ISIN: US45665G3039   30/11/2023
0,004 USD (+20,00%)
(+20,00%)   30/11/2023
Grafiek Infinity Pharmaceuticals Inc. Grafiek Infinity Pharmaceuticals Inc.

Infinity Pharmaceuticals Inc. in het nieuws

12 oktober 2023 · INFI DEADLINE ALERT: ROSEN, A HIGHLY RECOGNIZED LAW FIRM, Encourages Infinity Pharmaceuticals, Inc. Investors to Secure Counsel Before Important October 16 Deadline in Securities Class Action - INFI · Persbericht

11 oktober 2023 · INFINITY ONGOING INVESTOR DEADLINE ALERT: Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Infinity To Contact Him Directly To Discuss Their Options · Persbericht

9 oktober 2023 · SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Infinity Pharmaceuticals, Inc. - INFI · Persbericht

6 oktober 2023 · INFINITY ONGOING INVESTOR DEADLINE ALERT: Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Infinity To Contact Him Directly To Discuss Their Options · Persbericht

5 oktober 2023 · INFI IMPORTANT DEADLINE: ROSEN, A TOP RANKED LAW FIRM, Encourages Infinity Pharmaceuticals, Inc. Investors to Secure Counsel Before Important October 16 Deadline in Securities Class Action - INFI · Persbericht

29 september 2023 · SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Infinity Pharmaceuticals, Inc. - INFI · Persbericht

28 september 2023 · INFINITY DEADLINE REMINDER: Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $100,000 In Infinity To Contact Him Directly To Discuss Their Options · Persbericht

27 september 2023 · ROSEN, A LONGSTANDING LAW FIRM, Encourages Infinity Pharmaceuticals, Inc. Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action - INFI · Persbericht

23 september 2023 · INFINITY INVESTOR DEADLINE APPROACHING: Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $100,000 In Infinity To Contact Him Directly To Discuss Their Options · Persbericht

2 september 2023 · Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $100,000 In Infinity To Contact Him Directly To Discuss Their Options · Persbericht

Profiel Infinity Pharmaceuticals Inc.

Biotechnologie
Fabricage van farmaceutische preparaten
Gezondheidstechnologie
Productie

Website: www.infi.com

Hoofdzetel: Cambridge, Massachusetts vlag Verenigde Staten

CEO: Adelene Perkins

Werknemers: 451

Aandelen Infinity Pharmaceuticals Inc.

Effecten: 90,76 miljoen

Winst per aandeel (12 maand):  PLUS

Mijn selecties